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Abstract
Alzheimer disease (AD) is an age-dependent neurodegenerative disease characterized by the formation of b–amyloid (Ab)-
containing senile plaque. The disease could be induced by the administration of Ab peptide, which was also known to
upregulate inducible nitric oxide synthase (iNOS) and stimulate neuronal apoptosis. The present study is aimed to elucidate
the cellular effect of resveratrol, a natural phytoestrogen with neuroprotective activities, on Ab-induced hippocampal
neuron loss and memory impairment. On adult Sprague-Dawley rats, we found the injection of Ab could result in a
significant impairment in spatial memory, a marked increase in the cellular level of iNOS and lipid peroxidation, and an
apparent decrease in the expression of heme oxygenase-1 (HO-1). By combining the treatment with Ab, resveratrol was able
to confer a significant improvement in spatial memory, and protect animals from Ab-induced neurotoxicity. These
neurological protection effects of resveratrol were associated with a reduction in the cellular levels of iNOS and lipid
peroxidation and an increase in the production of HO-1. Moreover, the similar neurological and cellular response were also
observed when Ab treatment was combined with the administration of a NOS inhibitor, N(G)-nitro-L-arginine methyl ester
hydrochloride (L-NAME). These findings strongly implicate that iNOS is involved in the Ab-induced lipid peroxidation and
HO-1 downregulation, and resveratrol protects animals from Ab-induced neurotoxicity by suppressing iNOS production.
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Introduction
Alzheimer’s disease (AD) is a neurodegenerative disorder, which
could lead to a severe dementia and affect multiple cognitive and
behavioral functions. Mainly due to the worldwide aging problem,
AD has accounted for about 60% of all dementia [1] and has
obviously become a serious health problem to be coped with. In
2000, 25 million people in the world were diagnosed to suffer from
AD, and this number is expected to increase to 114 million by 2050
[2].Amyloidbprotein(Ab),a39-to43-aminoacidpeptidefragment
derived from an amyloid precursor protein via a sequential cleavage
by b-a n dc- secretases, is currently believed to be tightly related to
the pathogenesis of AD. Consequently, targeting on Ab production
and amyloid fibril aggregation has represented an attractive
therapeutic strategy for the treatment of AD [3]. Although the
precisemechanismofAb-inducedneuronaldeathandADisnotwell
understood, Ab neurotoxicity has been connected with various
cellular impacts,including Ca
2+ influx, glutamate accumulation, and
oxidative stress [4]. Since the aging process is typically associated
with an augment in the reactive oxygen species (ROS) production
together with a parallel decline in the ability to defend ROS attack,
oxidative stress is thus speculated to be the primary causative event
that contributes to the progress of AD [5].
Nitric oxide (NO) is synthesized from L-arginine by nitric oxide
synthase (NOS). It is also assumed to play a detrimental role in the
pathological process of AD. In fact, three isoforms of NOS have
been isolated and named by the tissues from which they were first
cloned. Neuronal NOS (nNOS) and endothelial NOS (eNOS) are
constitutively expressed and calcium dependent, while inducible
NOS (iNOS) is expressed in response to immunologic challenge or
tissue injury, but is calcium independent. In early studies, nitric
oxide was reported to be excessively produced in AD [6]. It not
only damaged DNA but also induced the production of
peroxynitrite, which in turn destructed mitochondria and reduced
ATP formation [7]. As a high level of Ab was as well reported to
activate microglia and upregulate the expression of iNOS [8],
conceivably, the resulted high level of NO should have contributed
to the development of neural damage in AD patients.
Resveratrol (3,5,49-trihydroxystilbene) is a naturally occurring
polyphenol, and belongs to the phytoalexin family. It can be
isolated from the seeds of a variety of plant species including
grapes and peanuts, and constitutes one of the valuable ingredients
of red wine [9,10]. This natural product has been reported to
exhibit certain beneficial effects in the treatment of ischemia [11]
and neurodegenerative disease [12]. Our recent studies also
demonstrated that resveratrol could protect rats from ischemia-
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duced neurotoxicity and free radical overloading in substantia
nigra [13]. More interestingly, the cellular level of NO seems to be
modulated by resveratrol, and this regulatory effect appears to be
tissue (or enzyme) dependent. Resveratrol could stimulate eNOS
gene expression and eNOS protein phosphorylation, leading to an
increase in NO level that, by an unknown mechanism, gives rise to
a protective and vasorelaxation effect [14,15]. However, resver-
atrol was also demonsrated to suppress the iNOS activity by
inhibiting NF-kB binding activity and post-transcriptional mod-
ification, thereby protected neurons from Ab-induced neurotox-
icity [16].
Heme oxygenase-1 (HO-1) is a 32 kDa stress induced protein
that catalyzes the degradation of heme to biliverdin, Fe
2+, and
carbon monoxide [17,18]. It also protects cells by catalyzing the
catabolism of pro-oxidant metalloporphyrins to bile pigments with
its free radical scavenging capabilities [19]. The activity of HO-1 is
critical to oxidative challenge. In several stress-related pathological
conditions, including hypoxia, atherosclerosis, and inflammation,
the expression of HO-1 gene and HO-1 enzyme activity were
found to be greatly enhanced [20–22]. Judging from the results
obtained from some previous in vitro and in vivo studies, HO-1 was
also suggested to be a key factor for neuroprotection. The
overexpression of HO-1 resulted in a relatively higher resistance to
glutamate- and H2O2-mediated oxidative damage and MPTP- or
b-amyloid1–40-induced neurotoxicity [23–26]. The connection
between the function of resveratrol and the level of HO-1,
however, is rather paradoxical. Resveratrol was evidenced, in vitro,
to augment cellular antioxidant defense capacity by activating
HO-1 expression through the Nrf2-ARE signaling process,
thereby protecting PC12 cells from oxidative stress [27].
Conversely, the effectiveness of resveratrol in ameliorating the
toxicity of tBH was proved to arise from the suppression of HO-1
production [28]. The role of resveratrol on HO-1 expression
apparently requires more extensive studies to clarify.
Growing bodies of evidence have supported the fact that the
chronic administration of resveratrol could effectively protect
various tissues against ischemic injury by reducing the free radical
production [11,13]. And, these protection activities seemed to
attribute, at least partly, to the enzymatic activities and the cellular
levels of iNOS and HO-1. To gain a further insight into the
biological roles of resveratrol, we attempt, in this study, to
elucidate the correlation between its neuroprotection effect and
the iNOS and HO-1 production with a model of Ab-induced
cognitive dysfunction and neuronal damage.
Materials and Methods
Animals
Adult male Sprague-Dawley (SD) rats weighing 500–550 g were
purchased from the BioLasco Taiwan Co., Ltd and used in the
present study. Animals were housed individually, in hanging wire
cages, in a temperature-controlled animal colony at 24uC with a
normal 12-h:12-h light/dark cycle. The animals had free access to
food and water and were allowed to acclimate to the light/dark
cycle for at least 1 week before being used in the experiments. The
protocols for the animal care and treatment were approved by the
Animal Care and Use Committee of National Chia-Yi University
(Approval No.: 2006006).
Experimental procedures
Based on recent in vivo and in vitro studies, the peptide Ab(25–35) was
reported to perform similarly as the full-length Ab(1–42) [29] in
generating the critical neurotoxic effects and amyloid fibril
aggregation as in AD [30–33]. Investigations with the use of
Ab(25–35) in animal models would provide a convenient model in
understanding more AD-related mechanisms. Therefore, in this
study, the peptide was used. Ab(25–35) (100 mM/5 ml)(Tocris, Bristol,
UK) was first dissolved in saline and allowed to aggregate at 37uCf o r
seven days before use. Each rat was anesthetized with sodium
pentobarbitol (50 mg/kg, i.p.) and placed on a stereotaxic instrument
(Stoelting, USA). The animal’s skull was exposed, and a 23-gauge
guide cannula (model C313G, Plastic-one Products, Roanoke, VA)
was implanted in the lateral ventricle (AP, 21.8; DV, 23.5, ML,
62.5 from bregma). To prevent clogging, a size 0 insect pin (Carolina
Biological Supply, Burlington, NC) wasalso inserted into the cannula.
After that, several screws were put onto the skull, and the assembly
was cemented in place by using dental cement (Plastic-one Products,
Roanoke, VA). To avoid infection, all surgically treated rats were
given antibiotic, penicillin, every day for the first three days after the
surgery.Toeachrat,Ab25–35 (100 mM/5 ml)(Tocris,Bristol,UK) was
injected, with 0.5 ml/min, directly into the lateral ventricle through
the cannula by means of a Hamilton microsyringe and a mini-pump.
The injection lasted for 10 min, and the needle, along with the
syringe, was left on the injection site for another 2 min to ensure the
completion of Ab infusion. By the same procedure, Ab was injected
once a day for 7 days. To investigate the effect of resveratrol or L-
NAME on the Ab-induced neurotoxicity, resveratrol (100 mM/5 ml,
i.c.v) or L-NAME (200 mg/5 ml) was injected everyday thirty minutes
after the Ab administration.
Morris water maze
To test for the biological effects of Ab and resveratrol on animal’s
spatial memory, rats were randomly separated into five groups
(n=5foreach group)and treateddifferently:sham group,Abgroup
(Ab,1 0 0mM/5 ml/day, 7 days, i.c.v), Ab and resveratrol (100 mM/
5 ml/day, 7 days, i.c.v) group, Ab and L-NAME (200 mg/5 ml/day,
7 days,i.c.v)group,and resveratrol(100 mM/5 ml/day,7 days,i.c.v)
group. The experimental device for the test was a circular tank
(180 cm diameter; 60 cm height) filled with water at temperature
2362uC. At the midpoint of one quadrant, 1 cm below the water
level, was placed a target platform (10610 cm). It was made to have
equal distance from the center to the edge of the tank. The water
tank was placed in a test room with many major visual cues. The
acquisition training session was performed 7 days starting from the
injection of Ab or other chemicals. Rats were arbitrarily left in the
tank, facing the wall, and allowed to swim freely. They were gently
directed to the escape platform if they could not find the platform
within 2 minutes. The animals were then allowed to stay on the
platform for 2 minutes. The procedure was repeated 4 times a day
with each animal, and the escape latency time was recorded [34].
Western blot
After the behavioral test, the rats from each group were
decapitated and their brains were rapidly removed. Following
dissection, each hippocampus was weighed and rapidly homoge-
nized in a 6 volumes of ice-cold homogenizing buffer (T-PER,
Pierce, USA). Total hippocampal proteins were isolated by
centrifugation and electrophoretically separated on an 8% sodium
dodecylsulfate (SDS) polyacrylamide gel. The resolved proteins on
the gel were electro-blotted onto a polyvinylidene difluoride
membrane. Immunoblotting analysis was then performed by using
monoclonal antibody anti-iNOS (1:2000 dilution) or anti-HO-1
(1:5000 dilution) (Cell Signaling, USA), as the primary antibody.
The ultimate signals from each analysis were visualized with an
enhanced chemiluminescence assay (RPN 2108; Amersham
International, Amersham, UK). The intensities of the detected
Effect of Resveratrol on Ab-induced Neurotoxicity
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tion with AlphaEase software (Alpha Innotech Corp., CA) [35].
Determination of neuromuscular coordination
Rota-rod accelerating test was also performed to each animal. It
was to examine the possible defects in neuromuscular coordination
that might occur on the chemically treated rats [13]. Before the
stereotaxic surgery, each rat was placed in a rota-rod apparatus
(UgoBasile,Varese, Italy)andsubjectedtoacceleratingtest.The rat
was placed on the rotating rod (at the slowest speed, 4 rpm) for
2 minutes. The rats that could not hold on the rod for more than
2 minutes were excluded from the further experiments, including
stereotaxic surgery and chemical treatment. For the qualified rats
that were used in chemical treatment, starting from the 6
th day after
surgery, the rats were trained per day as described above for 2 days.
At day 7 after surgery, the rotational speed of the rod was then
switched to its maximum speed of 40 rpm, and the length of the
time rats could grasp at the rod was measured. The test score is the
average number of seconds that rats could hold onto the rod per
trial. The variation in rota-rod performance among rat groups was
used to evaluate the impairment of the motor coordination [36].
Malondialdehyde (MDA) assay
In this study, we also perform a malondialdehyde (MDA) assay to
evaluate the level of lipid peroxidation in hippocampus derived from
the rats that were treated with different chemicals. The rats were
sacrificed after surgery and behavioral test, and the hippocampus
were carefully dissected and immediately stored at 270uC. The
content of MDA was determined by a modified procedure of Li et al
[37]. Each hippocampus section (100 mg) was homogenized in 1 ml
of 10 mM phosphate buffer (pH 7.4). After centrifugation at
12,0006g for 20 min, the MDA content in the supernatant was
assayed by the thiobarbituric acid (TBA) reaction, and the resulted
colored product was measured at 535 nm with spectrometer. The
levels of TBA reactive species were indicated as nmol/mg protein.
Histology evaluation of neuronal damage
Another set of chemically treated rat groups (n=4, each group)
were sacrificed, at day 7 of the surgery with an overdose of
pentobarbitol (100 mg/kg sodium pentobarbital, i.p.), and subse-
quently perfused transcardically with 0.9% NaCl and 10%
formalin. Following formalin perfusion, the rats were decapitated
and their brains were removed from the skulls and embedded in
paraffin blocks. Coronal sections (2 mm) through the brain were
stained with hematoxylin and eosin (H&E) for microscopic
evaluation. Each hemisphere was studied independently without
the examiner knowing the experimental conditions.
Statistical analysis
All data obtained in this experiment were expressed as mean 6
SEM. Significance of changes of Ab, iNOS and HO-1 was
determined by the nonparametric Mann-Whitney U test. Escape
latency and retention time were also compared among groups by
the nonparametric Mann-Whitney U test. We considered p,0.05
to be statistically significant.
Results
Ab administration significantly increased the Ab
accumulation in hippocampus and resveratrol treatment
decreased the hippocampal Ab accumulation
To establish a plausible rat model of AD, we first examined, by
immunobloting, whether the Ab25–35 peptide administration
would induce the Ab accumulation in hippocampus [33].
According to the manufacturer, the band near 43 kDa represents
the expression of Ab in rats. As compared with that of sham group
(Figure 1), a more than 4.5-fold increase in Ab protein level was
observed in the rat group with Ab peptide administration. Such
over-aggregation of hippocampal Ab did not occur if the rats were
injected with resveratrol alone. When combined with Ab peptide
treatment, resveratrol actually could significantly attenuate the Ab
accumulation that presumably would be induced by Ab peptide
injection. Similar to resveratrol, the drug, L-NAME, a NOS
specific inhibitor, also appeared to be a potent agent in preventing
Ab accumulation.
Resveratrol improved Ab-induced spatial memory
deficiency
Besides the suppression of Ab accumulation, the role of
resveratrol was also extended to exhibit a beneficial effect against
the Ab-induced spatial memory deficiency. In this experiment, the
escape latency was recorded after the rats were injected with Ab
peptide. In training trials, the escape latency time on the last day of
training (the 7th day of surgery) was 8.2162.13 seconds for sham
group, 21.2161.91 seconds for Ab (100 mM) treated group, and
10.7161.75 seconds for the rat group with a combined injection
of Ab and resveratrol (Figure 2). The escape latency time was
significantly prolonged in Ab treated rat group as compared with
that of sham group (p,0.01). However, there was no significant
difference between sham and Ab + resveratrol groups (p=0.979).
As compared with Ab group, Ab+ resveratrol group rats spent a
much shorter time on the target quadrant to reach the escape
platform, suggesting that resveratrol administration was rather
effective in improving the spatial recognition and memory, which
were obviously disrupted by Ab. These results, however, could not
exclude the possibility that the given surgery might also affect rat
swimming ability and influence the measurement of escape latency
time. To rule out the possibility, the swimming speed of rats was
also measured. The average swimming velocity of sham, Ab
treated, and Ab combined with resveratrol groups of rats were
23.3860.77, 22.361.65 and 21.2661.53 cm/sec, respectively. In
fact, no obvious defect in the swimming ability, from the tests of
the Morris Water Maze and the total square crossing, was
observed among different rat groups. In addition, based on the
results of rota-rod tests on the rats’ neuromuscular function, there
was again no apparent alteration among the differently treated rat
groups (Figure 3). The latency times of sham, Ab,A b combined
with resveratrol, and Ab combined with L-NAME were
150.21618.54, 180.25632.97, 172.7964.17, and 160.6769.43,
respectively. All these evidences pointed to the fact that, except for
the behavior alteration observed in spatial memory test, there was
little motor deficit occurred in the animals with or without various
chemical treatment.
Resveratrol reversed Ab-induced iNOS expression
To unravel the connection between iNOS and the Ab-induced
neurotoxicity, animals were treated with Ab,A b plus resveratrol,
or Ab plus L-NAME, and the iNOS level in each rat hippocampus
was analyzed by Western blotting. As shown in Figure 4, the
production of iNOS was markedly stimulated (,5 folds) by Ab
administration. Resveratrol treatment reversed the Ab-induced
iNOS overexpression, and L-NAME conferred a similar but more
profound effect, as that of resveratrol, on iNOS production
suppression. These results clearly demonstrated that resveratrol
could effectively suppress iNOS expression that was stimulated by
Ab.
Effect of Resveratrol on Ab-induced Neurotoxicity
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Since oxidative stress has been implicated as a major causality
of neuronal damage in AD, and HO-1 appears to be a critical
enzyme to defend neurons against oxidative stress, the detection
of hippocampal HO-1 level was also included in the list of our
investigation. In comparison with the sham group, the rats
injected with Ab peptide revealed an apparent decline in the
hippocampal HO-1 expression (,40% of sham) (Figure 5).
Resveratrol, however, caused a ,30% increase in HO-1
production with or without the co-treatment with Ab peptide.
Interestingly, the NOS inhibitor L-NAME, which has never been
reported to modulate HO-1 gene expression, also depressed the
Ab-induced inhibition in HO-1 production, though it was not as
effective as resveratrol.
Resveratrol suppressed lipid peroxidation
To further bear out the anti-oxidative activity of resveratrol,
the level of lipid peroxidation was assayed by measuring the
level of hippocampal MDA. The detected average MDA
amount from sham rats was 6.062.0 ng/mg protein. It was
remarkably lower than that from the rats treated with Ab
peptide (17.363.5 ng/mg protein(p=0.005)). When the re-
sveratrol was given alone or together with the Ab peptide, the
average amount of MDA declined to 5.461.6 or 7.663.4 ng/
mg protein respectively. Similar to the effect of resveratrol, the
high MDA level resulted from the stimulation of Ab could be
effectively reduced by L-NAME to 5.563.0 ng/mg protein
(Figure 6).
Resveratrol protected rats from Ab-induced neuronal
death
Resveratrol also reduced the severe Ab-induced neuronal
damage. The histological photographs for the examination of
neuronal damage from the differently treated rat groups are
shown in Figure 7. The rats subjected to Ab injection revealed a
severe neuronal damage at hippocampus with much more
shrunk and damaged neurons than that of sham group. The
extent of Ab-induced neuronal damage was significantly
decreased at the hippocampus derived from the rats treated
with Ab plus resveratrol. Similarly, a much lower level of
hippocampal neuron damage was observed in the rats treated
with Ab plus L-NAME.
Discussion
In the present study, we have extensively investigated the
neuroprotective activity of resveratrol by using a rat model of
Alzheimer’s disease. A chronic (7 days) i.c.v. injection of 100 mM
Ab peptide could result in an impaired learning and memory
behavior on rats. This memory impairment apparently was
associated with lipid peroxidation elevation, HO-1 downregula-
tion, iNOS overexpression, and severe neuronal loss. By using the
NOS inhibitor, L-NAME, we have clarified the role of iNOS in
the Ab-induced memory deficiency, lipid peroxidation generation,
and neuronal damage. The major findings from this study also
have shed considerably more light on the biological role of
resveratrol. It could provide beneficial effects on the recovery of
Figure 1. Effects of resveratrol on hippocampal Ab accumulation. (A) Western blot analysis on the Ab protein from sham rats (sham), the rats
with Ab25–35 administration for seven days (Ab), the rats given with Ab25–35 and resveratrol (Ab+Res), the rats administered with resveratrol only (Res),
and the rats combined with Ab25–35 and L-NAME administration (Ab+L-NAME); (B) Relative Ab protein quantified as compared with sham group
(normalized to 100%). Data were indicated as mean 6 SEM values (n=5). **p,0.01 was considered significantly different from sham values by Mann-
Whiney U test. ##p,0.01 was considered significantly different from Ab values by Mann-Whiney U test.
doi:10.1371/journal.pone.0029102.g001
Effect of Resveratrol on Ab-induced Neurotoxicity
PLoS ONE | www.plosone.org 4 December 2011 | Volume 6 | Issue 12 | e29102learning and memory, suppress the production of hippocampal
iNOS, prevent the accumulation of lipid peroxidation products,
and enhance the expression of HO-1. As the chronic administra-
tion of resveratrol also protected animals from Ab-induced
neuronal loss, it is reasonably speculated that the improvement
in spatial memory by resveratrol might be ascribed to its
effectiveness in reducing the levels of oxidative stress and the
Ab-induced neuronal loss.
Based on some rodent behavioral studies, including the Morris
water maze and passive avoidance [38], administration of Ab25–35
was found to provoke a significant memory impairment. In order
to mimic the progress of AD, we infused Ab peptide into lateral
Figure 2. Effects of resveratrol or L-NAME on escape latency in the training trials of the water maze task. The different treated rats were
subjected to the analysis: the rats were infused icv with vehicle (sham), the rats with Ab25–35 administration for seven days (Ab), the rats with the
injection of Ab25–35 and resveratrol (Ab+Res), the rats administered with resveratrol only (Res), and the rats with Ab25–35 and L-NAME administration
(Ab+L-NAME). Data were represented as mean 6 SEM values (n=5). **p,0.01 was considered significantly different from sham values by Mann-
Whiney U test.
doi:10.1371/journal.pone.0029102.g002
Figure 3. Effects of Ab, resveratrol and L-NAME administration on the retention time of rota-rod. The training procedure is as described
in Materials and Method. Bars represent mean 6 SEM values (n=5).
doi:10.1371/journal.pone.0029102.g003
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plausible as Ab peptide induction indeed caused the Ab
accumulation and spatial memory impairment. Our results are
well consistent with that of other studies [39–40]. With this model,
we have one step further demonstrated that the chronic treatment
of resveratrol (100 mM, i.c.v.) could effectively eliminate the
formation of Ab in hippocampus and protect the rat from the
impairment of Ab-induced spatial memory. The observed effect of
resveratrol on the avoidance of neurotoxic Ab accumulation
conceivably has contributed greatly to the improvement of rat’s
memory.
Nitric oxide, a short-lived messenger, has been evidenced to be
involved in the physiological and pathophysiological development
of Alzheimer’s disease [41,42]. Our results have indicated that the
synthesis of iNOS was greatly stimulated by Ab injection. This
presumable would lead to a drastic increase in the concentration of
NO in hippocampus. Furthermore, such Ab-induced stimulation in
iNOS production could be reversed by resveratrol as well as the
NOS inhibitor, L-NAME. In fact, the similar effect of resveratrol on
Ab-induced iNOS expression was also observed in C6 glioma cells
[43]. According to previous studies, the modulation of resveratrol
on both Ab accumulation and iNOS regulation may not be so
surprising. The activation of iNOS gene by Ab is controlled by the
transcription factor NF-kB [43], which is known to regulate iNOS
transcription by bindingto the regulatoryregionof iNOS gene [44].
In addition, Ab treatment was reported to result in the activation of
NF-kB in various brain regions and cell types [45,46], and
resveratrol was shown to markedly attenuate the Ab-induced NF-
kB nuclear translocation [43,47]. Based on these, it is suggested that
theregulationpathwaytriggeredbyresveratrol isto decreasetheAb
accumulation, which in turn suppresses Ab-induced NF-kB
translocation, or activation, and leads to the downregulation of
iNOS. More interestingly, the decrease in iNOS by resveratrol
might confer a further decline in Ab accumulation as blocking the
iNOS expression (i.e. by L-NAME) appeared to reversely suppress
the accumulation of Ab (Figure 1).
As the neuroprotective role of HO-1 has been described in
earlier studies [31], it has raised our interest in investigating the
possible cellular modulation of resveratrol on the gene expression
of HO-1. HO-1 overproduction was detected in hippocampus and
cortex in AD patients, but not in normal control preparations [48].
In addition, HO-1 gene expression was found to be co-localized
with neurons, astrocytes, and gliocytes [49], and its gene
upregulation was believed to be a relatively early event in the
pathogenesis of AD [49,50]. A piece of direct evidence for this was
proposed based on a transgenic mice model, in which the long-
term overexpression of HO-1 was found to enhance iron loading
and the phosphorylation (Ser199/202/396) and aggregation of tau
[51]. In contradistinction to the enhanced HO-1 expression
documented from AD patients, the suppression of HO-1
production in the cerebral spinal fluid and choroids plexus
epithelials cell were also reported [26,49,50]. In contrast to that
from the previous in vitro experiment with PC12 cells [52], our
results showed that the Ab chronic treatment in vivo induced a
decrease, rather than an increase, in the HO-1 expression. And,
this could be reversed by the co-treatment with resveratrol. As a
matter of fact, the results obtained by using resveratrol in the
current study were similar to that of another study by using
Figure 4. Drug effects on the hippocampal iNOS expression. (A) Western blot analysis on sham rats (sham), the rats with Ab25–35
administration for seven days (Ab), the rats with injection of Ab25–35 and resveratrol (Ab+Res), the rats administered with resveratrol only (Res), and
the rats injected with Ab25–35 and L-NAME (Ab+L-NAME); (B) Relative iNOS level quantified as compared with sham group (normalized to 100%). Data
were represented as mean 6 SEM values (n=5). *p,0.05 was considered significantly different from sham values by Mann-Whiney U test. #p,0.05
was considered significantly different from Ab values by Mann-Whiney U test.
doi:10.1371/journal.pone.0029102.g004
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(80 mg/d for 14.5 months) appeared to upregulate HO-1, and the
increase in HO-1 production was associated with a lower
discrimination learning error scores in aged beagles [53]. It is of
particular interest that, in analogy to the effect conferred by
resveratrol, L-NAME also showed a depression activity on HO-1
expression, suggesting that HO-1 gene regulation is, at least in
part, mediated by iNOS.
Figure 5. Drug effects on the hippocampal HO-1 expression. (A) Western blot analysis on sham rats (sham), the rats with Ab25–35
administration for seven days (Ab), the rats with injection of Ab25–35 and resveratrol (Ab+Res), the rats administered with resveratrol only (Res), and
the rats injected with Ab25–35 and L-NAME (Ab+L-NAME); (B) Relative iNOS level quantified as compared with sham group (normalized to 100%). Data
were represented as mean 6 SEM values (n=5). *p,0.05 was considered significantly different from sham values by Mann-Whiney U test. #p,0.05
was considered significantly different from Ab values by Mann-Whiney U test.
doi:10.1371/journal.pone.0029102.g005
Figure 6. Drug effects of resveratrol on the hippocampal MDA level. The rats were infused icv with vehicle (sham), the rats with Ab25–35
administration for seven days (Ab), the rats injected with Ab25–35 and resveratrol (Ab+Res), the rats administered resveratrol only (Res), and the rats
injected with Ab25–35 and L-NAME (Ab+L-NAME). Data were represented as mean 6 SEM values (n=5). *p,0.05 was considered significantly different
from sham values by Mann-Whiney U test. #p,0.05 was considered significantly different from Ab values by Mann-Whiney U test.
doi:10.1371/journal.pone.0029102.g006
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clinical and basic researches, have highlighted to the fact that free
radicals and oxidative stress are associated with aging and AD.
Free radical attack might cause lipid peroxidation, protein
peroxidation, DNA peroxidation, and other oxidative stress, and
conceivably is the central causality in age-related diseases [54]. It is
thus believed that some antioxidants should bear the potential to
attenuate the cognitive decline in AD and retard the progress of
the disease [55]. In the current study, we have measured the level
of the MDA derived from the lipid membrane oxidation to reflect
the overall degree of free radical attack. Our results revealed a fact
that resveratrol could reverse the Ab-induced MDA overproduc-
tion. It should also be noted that L-NAME treatment also gave a
similar effect as that of resveratrol in decreasing the MDA level.
In conclusion, the spatial memory impairment and neuronal
death occurred in the progress of AD is strongly correlated to the
expression of iNOS. The level of iNOS mediates the Ab-induced
lipid peroxidation and HO-1 expression, and resveratrol protects
rats from Ab-induced neurotoxicity through the downregulation of
iNOS.
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